Businesses have the power to democratize innovation.
However, the incentives of the business model are key to its outcomes.
This fireside chat with Dr. Gary Nabel will center on frugal innovation and how economic incentives can align with good public health outcomes to derisk the business of saving lives.
Dr. Gary J. Nabel M.D., Ph.D. is Chief Scientific Officer, Global Research and Development, and Head of the North American R&D Hub at Sanofi. In addition to serving as Senior Vice President for the company, Dr. Nabel also oversees the Breakthrough Lab, which developed the first trispecific antibodies now in development for HIV as published in Science, as well as, cancer immunotherapies and novel vaccines. The Chief Scientific Office sponsors the iAwards, the Postdoctoral and Innovation Fellows Programs, and the Global Science Awards.
Wednesday, February 20 at 5:00pm
Wilder Pavilion, 165 Adamian Academic Center, 175 Forest Street, Waltham, MA 02452